1
|
Ekhtiari H, Khojasteh Zonoozi A, Rafei P, Abolghasemi FS, Pemstein D, Abdelgawad T, Achab S, Ghafri HA, Al’Absi M, Bisch M, Conti AA, Ambekar A, Arunogiri S, Bhad R, Bilici R, Brady K, Bunt G, Busse A, Butner JL, Danesh A, El-Khoury J, Omari FE, Jokūbonis D, de Jong C, Dom G, Ebrahimi M, Fathi Jouzdani A, Ferri M, Galea-Singer S, Parker DG, Higuchi S, Kathiresan P, Khelifa E, Kouimtsidis C, Krupitsky EM, Long J, Maremmani I, McGovern G, Mohaddes Ardabili H, Rahimi-Movaghar A, Rataemane ST, Sangchooli A, Sibeko G, Vella AM, Vista SBD, Zare-Bidoky M, Zhao M, Javed A, Potenza MN, Baldacchino AM. World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveys. Front Psychiatry 2024; 15:1230318. [PMID: 38528974 PMCID: PMC10961370 DOI: 10.3389/fpsyt.2024.1230318] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/28/2023] [Accepted: 02/13/2024] [Indexed: 03/27/2024] Open
Abstract
Addiction medicine is a dynamic field that encompasses clinical practice and research in the context of societal, economic, and cultural factors at the local, national, regional, and global levels. This field has evolved profoundly during the past decades in terms of scopes and activities with the contribution of addiction medicine scientists and professionals globally. The dynamic nature of drug addiction at the global level has resulted in a crucial need for developing an international collaborative network of addiction societies, treatment programs and experts to monitor emerging national, regional, and global concerns. This protocol paper presents methodological details of running longitudinal surveys at national, regional, and global levels through the Global Expert Network of the International Society of Addiction Medicine (ISAM-GEN). The initial formation of the network with a recruitment phase and a round of snowball sampling provided 354 experts from 78 countries across the globe. In addition, 43 national/regional addiction societies/associations are also included in the database. The surveys will be developed by global experts in addiction medicine on treatment services, service coverage, co-occurring disorders, treatment standards and barriers, emerging addictions and/or dynamic changes in treatment needs worldwide. Survey participants in categories of (1) addiction societies/associations, (2) addiction treatment programs, (3) addiction experts/clinicians and (4) related stakeholders will respond to these global longitudinal surveys. The results will be analyzed and cross-examined with available data and peer-reviewed for publication.
Collapse
Affiliation(s)
- Hamed Ekhtiari
- Department of Psychiatry, University of Minnesota, Minneapolis, MN, United States
- Laureate Institute for Brain Research, Tulsa, OK, United States
| | - Arash Khojasteh Zonoozi
- Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
- Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Parnian Rafei
- Trinity College Institute of Neuroscience (TCIN), Trinity College Dublin, Dublin, Ireland
| | - Fateme Sadat Abolghasemi
- Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
- Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Dan Pemstein
- Political Science and Public Policy & Challey Institute, North Dakota State University, Fargo, ND, United States
| | | | - Sophia Achab
- Faculty of Medicine, Sociological and Psychological Research Unit, Department of Psychiatry, University of Geneva, Geneva, Switzerland
| | - Hamad Al Ghafri
- National Rehabilitation Center, Abu Dhabi, United Arab Emirates
| | - Mustafa Al’Absi
- Department of Psychiatry, University of Minnesota, Minneapolis, MN, United States
| | - Michaël Bisch
- Pôle Hospitalo-Universitaire de Psychiatrie d’Adultes et d’Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France
| | - Aldo Alberto Conti
- Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, United Kingdom
| | - Atul Ambekar
- National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India
| | - Shalini Arunogiri
- Monash Addiction Research Centre, Eastern Health Clinical School, Melbourne, VIC, Australia
| | - Roshan Bhad
- National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India
| | - Rabia Bilici
- Faculty of Medicine, Department of Psychology, Istanbul Ticaret University, Istanbul, Türkiye
| | - Kathleen Brady
- Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States
| | - Gregory Bunt
- School of Medicine, New York University, New York City, NY, United States
| | - Anja Busse
- Prevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC), Vienna, Austria
| | - Jenna L. Butner
- Department of Internal Medicine, Yale School of Medicine, New Haven, CT, United States
| | - Ahmad Danesh
- Division of Prevention Science, University of California, San Francisco, San Francisco, CA, United States
| | | | - Fatima El Omari
- Faculty of Medicine, University Mohammed Vth of Rabat, Rabat, Morocco
| | - Darius Jokūbonis
- Republican Center for Addictive Disorders, Lithuanian University of Health Sciences, Kaunas, Lithuania
| | - Cor de Jong
- Behavioral Science Institute, Radboud University, Nijmegen, Netherlands
| | - Geert Dom
- Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium
| | - Mohsen Ebrahimi
- Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
| | - Ali Fathi Jouzdani
- Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
| | - Marica Ferri
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
| | - Susanna Galea-Singer
- DigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, United Kingdom
- National Health Service (NHS) Fife Addiction Services, Cameron Hospital, Windygates, United Kingdom
| | | | - Susumu Higuchi
- National Hospital Organization Kurihama Medical and Addiction Center, Yokosuka, Japan
| | - Preethy Kathiresan
- Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India
| | - Emira Khelifa
- Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia
| | - Christos Kouimtsidis
- National Office for Addressing Drugs, Athens, Greece
- Surrey and Borders Partnership, National Health Service (NHS) Foundation Trust, Leatherhead, United Kingdom
- Department of Medicine, Imperial College London, London, United Kingdom
| | - Evgeny M. Krupitsky
- Department of Addictions, Bekhterev National Medical Research Center for Psychiatry and Neurology, St. Petersburg, Russia
| | - Jiang Long
- Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - Icro Maremmani
- Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy
- UniCamillus, International Medical University in Rome, Rome, Italy
| | - Garrett McGovern
- Irish Chapter of International Society of Addiction Medicine (IRE-ISAM), Dublin, Ireland
| | - Hossein Mohaddes Ardabili
- Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
- Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Afarin Rahimi-Movaghar
- Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
| | | | - Arshiya Sangchooli
- Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia
| | - Goodman Sibeko
- Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa
| | - Anna Maria Vella
- Foundation for Social Welfare Services (FSWS), Sedqa, Santa Venera, Malta
| | - Salvador Benjamin D. Vista
- Department of Psychiatry and Behavioral Medicine, College of Medicine and Philippines General Hospital, University of the Philippines Manila, Manila, Philippines
| | - Mehran Zare-Bidoky
- Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
| | - Min Zhao
- Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, China
| | - Afzal Javed
- Pakistan Psychiatric Research Centre, Fountain House, Lahore, Pakistan
| | - Marc N. Potenza
- Department of Psychiatry and Child Center, Yale School of Medicine, New Haven, CT, United States
- Connecticut Mental Health Center, New Haven, CT, United States
- Connecticut Council on Problem Gambling, Wethersfield, CT, United States
- Wu Tsai Institute and Department of Neuroscience, Yale University, New Haven, CT, United States
| | - Alexander Mario Baldacchino
- DigitAS Project, Population and Behavioural Science, School of Medicine, University of St Andrews, St Andrews, United Kingdom
| |
Collapse
|
2
|
Al Ghafri H, Hasan N, Elarabi HF, Radwan D, Shawky M, Al Mamari S, Abdelgawad T, El Rashid A, Kodera A, Al Kathiri H, Lee AJ, Wanigaratne S. The impact of family engagement in opioid assisted treatment: Results from a randomised controlled trial. Int J Soc Psychiatry 2022; 68:166-170. [PMID: 33325311 DOI: 10.1177/0020764020979026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
BACKGROUND Family interventions in substance use disorders (SUD) treatment is limited despite the evidence for benefits. Providing family interventions is hampered by patient resistance, social stigma, logistics and factors related to the capacity of the treatment programmes. AIMS The purpose of the study was to examine the association between family engagement in treatment, and opioid use defined by percentage negative opioid screen and rate retention in treatment defined by completion of study period. METHODS Data from a 16-week outpatient randomised controlled trial (RCT) of 141 adults with opioid use disorder (OUD) receiving Opioid Assisted Treatment (OAT) using buprenorphine/naloxone film (BUP/NX-F) was, used to examine the association between family engagement in and opioid use and rate of retention in treatment. Multiple logistic regression was, applied to examine the independent prediction of family engagement on opioid use and rate retention in treatment. RESULTS Family engagement was significantly associated with retention in treatment (Spearman's rho 0.25, p < 0.01) and was subsequently found to increase the likelihood of retention in treatment by approximately 3-fold (adjusted odds ratio (OR) 2.95, 95% CI 1.31-6.65). CONCLUSION Family engagement in treatment is an independent predictor of retention in treatment but not opioid use in adults receiving OAT. It is, recommended that SUD treatment programmes integrate family related interventions in mainstream treatment. Delivering a personalised multicomponent family programme using digitised virtual communications that has been increasingly utilised during the Covid-19 pandemic is highly suggested.
Collapse
Affiliation(s)
- Hamad Al Ghafri
- National Rehabilitation Centre, Abu Dhabi, United Arab Emirates
| | - Nael Hasan
- National Rehabilitation Centre, Abu Dhabi, United Arab Emirates
| | - Hesham Farouk Elarabi
- National Rehabilitation Centre, Abu Dhabi, United Arab Emirates.,Division of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - Doa Radwan
- National Rehabilitation Centre, Abu Dhabi, United Arab Emirates.,Institute of Psychiatry, Ain Shams University, Cairo, Egypt
| | - Mansour Shawky
- National Rehabilitation Centre, Abu Dhabi, United Arab Emirates.,Faculty of Medicine, Cairo University, Cairo, Egypt
| | - Samya Al Mamari
- National Rehabilitation Centre, Abu Dhabi, United Arab Emirates
| | - Tarek Abdelgawad
- National Rehabilitation Centre, Abu Dhabi, United Arab Emirates.,Faculty of Medicine, Assuit University, Asyut, Egypt
| | - Abuelgasim El Rashid
- National Rehabilitation Centre, Abu Dhabi, United Arab Emirates.,Academy of Clinical Sciences and Laboratory Medicine, Dublin, Ireland
| | - Ayman Kodera
- National Rehabilitation Centre, Abu Dhabi, United Arab Emirates
| | | | - Amanda J Lee
- Medical Statistics Team, University of Aberdeen, Aberdeen, UK
| | | |
Collapse
|